Financials Qiagen N.V.

Equities

QGEN

NL0015001WM6

Biotechnology & Medical Research

Market Closed - Nyse Other stock markets 04:00:02 2024-12-12 pm EST			5-day change	1st Jan Change
45.96 ^USD	-0.43%		+5.00%	+2.65%

Dec. 05	Qiagen Reports Over 1,000 Placements of EZ2 Connect Instrument Globally	MT
Dec. 05	Qiagen N.V. Presents at 7th Annual Evercore ISI HealthCONx Healthcare Conference, Dec-05-2024 10:50 AM

Projected Income Statement: Qiagen N.V.

income-statement-evolution-chart QIAGEN-N-V

Fiscal Period: December	2019	2020	2021	2022	2023	2024	2025	2026
Net sales ¹	1,526	1,870	2,252	2,142	1,965	1,980	2,090	2,235
Change	-	22.53%	20.39%	-4.89%	-8.23%	0.74%	5.57%	6.95%
EBITDA ¹	551.8	747.8	884.2	789.7	659	733.9	768.7	845.3
Change	-	35.53%	18.24%	-10.69%	-16.55%	11.36%	4.74%	9.96%
EBIT ¹	421.8	626.8	755	656.3	528.6	567.1	606.6	660.6
Change	-	48.6%	20.45%	-13.07%	-19.46%	7.28%	6.97%	8.9%
Interest Paid ¹	-74.18	-71.32	-54.48	-58.36	-53.41	-36.33	-28.5	-28.25
Earnings before Tax (EBT) ¹	-77.78	439.5	625.8	512.6	429.8	119.5	552.2	619.7
Change	-	-	42.41%	-18.09%	-16.15%	-72.2%	362.08%	12.22%
Net income ¹	-41.46	359.2	512.6	423.2	341.3	166.4	422.2	507.1
Change	-	-	42.71%	-17.44%	-19.35%	-51.23%	153.66%	20.11%
Announcement Date	2/4/20	2/9/21	2/8/22	2/10/23	2/6/24	-	-	-

¹USD in Million

Estimates

Fiscal Period: December	2019 Q4	2020 Q1	2020 Q2	2020 Q3	2020 Q4	2021 Q1	2021 Q2	2021 Q3	2021 Q4	2022 Q1	2022 Q2	2022 Q3	2022 Q4	2023 Q1	2023 Q2	2023 Q3	2023 Q4	2024 Q1	2024 Q2	2024 Q3	2024 Q4	2025 Q1	2025 Q2	2025 Q3	2025 Q4	2026 Q1	2026 Q2	2026 Q3
Net sales ¹	413.5	372.1	443.3	483.8	571.2	567.2	567.3	535	582	628.4	516	500	498	485.4	494.9	475.9	509.2	458.8	496.3	501.9	519.3	480.2	520.9	525.3	545.5	500.1	544.2	550.3
Change	-	-10.01%	19.13%	9.13%	18.07%	-0.7%	0.02%	-5.69%	8.79%	7.97%	-17.89%	-3.1%	-0.4%	-2.53%	1.95%	-3.83%	6.99%	-9.89%	8.18%	1.11%	3.46%	-7.53%	8.48%	0.85%	3.84%	-8.32%	8.82%	1.12%
EBITDA ¹	169.6	128.4	188.4	200.2	230.8	227.3	228.4	197	231.6	266.4	178.7	175.9	168.6	157.6	168	158.2	175.3	153.3	176.4	182.7	196	170.6	193.8	197.7	208	186.6	208	210
Change	-	-24.29%	46.79%	6.26%	15.25%	-1.51%	0.48%	-13.76%	17.59%	15.02%	-32.92%	-1.56%	-4.18%	-6.53%	6.65%	-5.87%	10.81%	-12.52%	15.04%	3.57%	7.31%	-13%	13.61%	2.04%	5.22%	-10.32%	11.51%	0.97%
EBIT ¹	138.6	100.1	159.9	170.3	196.5	194.7	196.4	164.6	199.3	231.6	146.2	143.5	134.9	124.2	135.6	126.4	142.4	117.8	140.9	148.8	157.9	126.7	150.3	154.7	170	145.6	167.1	168.4
Change	-	-27.78%	59.74%	6.5%	15.38%	-0.92%	0.87%	-16.19%	21.08%	16.21%	-36.87%	-1.85%	-5.99%	-7.93%	9.18%	-6.78%	12.66%	-17.28%	19.61%	5.61%	6.1%	-19.77%	18.65%	2.97%	9.88%	-14.35%	14.7%	0.82%
Charge d'intérêts ¹	-18.32	-18.92	-17.44	-18.05	-16.9	-13.54	-13.91	-14.58	-12.46	-13.54	-13.66	-16.29	-14.88	-14.45	-13.5	-13.02	-12.44	-10.29	-10.92	-11.48	-8.667	-9.333	-8.333	-8	-7.667	-8	-8	-8
Earnings before Tax (EBT)	68.94	-	108.8	27.9	256.5	-	149.9	151.5	-	-	-	95.72	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Change	-	-100%	-	-74.34%	819.18%	-100%	-	1.04%	-100%	-	-	-	-100%	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net income ¹	44.93	39.8	89.76	16.91	212.7	129.2	121.1	133.1	129.2	155.3	96.66	82.39	88.84	85.04	80.79	77.82	97.66	80.67	-183.5	98.06	252	-	-	-	-	-	-	-
Change	-	-11.42%	125.54%	-81.16%	1,157.75%	-39.24%	-6.32%	9.99%	-2.97%	20.22%	-37.76%	-14.76%	7.83%	-4.29%	-5%	-3.67%	25.5%	-17.4%	-	-	156.99%	-100%	-	-	-	-	-	-
Announcement Date	2/4/20	5/6/20	8/4/20	10/27/20	2/9/21	5/3/21	7/29/21	11/3/21	2/8/22	4/27/22	7/26/22	11/7/22	2/10/23	5/3/23	8/8/23	10/30/23	2/6/24	4/29/24	7/31/24	11/7/24	-	-	-	-	-	-	-	-

¹USD in Million

Estimates

Forecast Balance Sheet: Qiagen N.V.

Fiscal Period: December	2019	2020	2021	2022	2023	2024	2025	2026
Net Debt ¹	953	1,208	876	1,174	452	250	-134	-571
Change	-	26.76%	-27.48%	34.02%	-61.5%	-44.69%	-153.6%	-526.12%
Announcement Date	2/4/20	2/9/21	2/8/22	2/10/23	2/6/24	-	-	-

¹USD in Million

Estimates

Cash Flow Forecast: Qiagen N.V.

Fiscal Period: December	2019	2020	2021	2022	2023	2024	2025	2026
CAPEX ¹	118	132.8	189.9	129.2	149.7	157.8	162.1	172.6
Change	-	12.58%	43.01%	-31.95%	15.85%	5.42%	2.71%	6.45%
Free Cash Flow (FCF) ¹	212.9	325	449.1	586	309.7	295.9	463.8	536.6
Change	-	52.67%	38.18%	30.49%	-47.15%	-4.46%	56.73%	15.69%
Announcement Date	2/4/20	2/9/21	2/8/22	2/10/23	2/6/24	-	-	-

¹USD in Million

Estimates

Forecast Financial Ratios: Qiagen N.V.

Fiscal Period: December	2019	2020	2021	2022	2023	2024	2025	2026
Profitability
EBITDA Margin (%)	36.15%	39.98%	39.27%	36.88%	33.53%	37.07%	36.78%	37.81%
EBIT Margin (%)	27.63%	33.51%	33.53%	30.65%	26.9%	28.64%	29.02%	29.55%
EBT Margin (%)	-5.1%	23.5%	27.79%	23.94%	21.87%	6.04%	26.42%	27.72%
Net margin (%)	-2.72%	19.2%	22.77%	19.76%	17.37%	8.41%	20.2%	22.68%
FCF margin (%)	13.95%	17.38%	19.95%	27.37%	15.76%	14.95%	22.19%	24%
FCF / Net Income (%)	-513.55%	90.49%	87.61%	138.47%	90.75%	177.8%	109.85%	105.81%
Profitability
ROA	6.06%	9.02%	8.53%	6.81%	2.75%	5.24%	7.7%	8.09%
ROE	12.87%	18.85%	17.39%	12.9%	4.69%	12.79%	12.71%	12.5%
Financial Health
Leverage (Debt/EBITDA)	1.73x	1.61x	0.99x	1.49x	0.69x	0.34x	-	-
Debt / Free cash flow	4.48x	3.72x	1.95x	2x	1.46x	0.85x	-	-
Capital Intensity
CAPEX / Current Assets (%)	7.73%	7.1%	8.43%	6.03%	7.62%	7.97%	7.76%	7.72%
CAPEX / EBITDA (%)	21.38%	17.76%	21.48%	16.36%	22.72%	21.5%	21.09%	20.41%
CAPEX / FCF (%)	55.4%	40.86%	42.29%	22.05%	48.33%	53.33%	34.95%	32.16%
Items per share
Cash flow per share ¹	1.468	2.015	2.839	3.204	1.992	2.588	2.923	2.913
Change	-	37.31%	40.89%	12.86%	-37.82%	29.89%	12.96%	-0.34%
Dividend per Share ¹	-	-	-	-	-	-	-	-
Change	-	-	-	-	-	-	-	-
Book Value Per Share ¹	11.3	12.65	14.06	15.69	16.51	16.76	18.52	20.53
Change	-	11.97%	11.12%	11.64%	5.21%	1.5%	10.49%	10.88%
EPS ¹	-0.1856	1.577	2.278	1.897	1.48	0.7397	1.99	2.252
Change	-	-949.99%	44.44%	-16.74%	-21.98%	-50.02%	169.01%	13.18%
Nbr of stocks (in thousands)	219,691	220,581	220,214	220,869	221,337	222,258	222,258	222,258
Announcement Date	2/4/20	2/9/21	2/8/22	2/10/23	2/6/24	-	-	-